2022 Court Litigating Prima Facie Case 
Day on Torts
OCTOBER 3, 2022
M2021-00878-COA-R3-CV, 2022 WL 4490980 (Tenn. 28, 2022), plaintiff was a real estate professional involved in some capacity with Durham Farms, which was a large residential community. Here, the first issue was whether the TPPA applied to the facts of this case. In Charles v. McQueen , No. The TPPA, Tenn. Code Ann. §
Day on Torts
NOVEMBER 15, 2022
When a litigant has filed a motion to dismiss pursuant to the Tennessee Public Participation Act (TPPA), that motion should be analyzed under the provisions of the TPPA rather than under the traditional Tennessee Rule of Civil Procedure 12 analysis. E2021-01513-COA-R3-CV, 2022 WL 16559447 (Tenn. The Court of Appeals quoted Tenn.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Patently O
NOVEMBER 29, 2023
by Dennis Crouch The Supreme Court is set to consider several significant patent law petitions addressing a range of issues from the application of obviousness standards, challenges to PTAB procedures, interpretation of joinder time limits IPR, to the proper scope patent eligibility doctrine. More detail on each case below: MacNeil v.
Patently O
MARCH 31, 2024
In a recent decision, the Federal Circuit vacated a judgment of invalidity and remanded for a new trial, holding that the district court’s jury instruction on objective indicia of nonobviousness constituted prejudicial legal error. The case, Inline Plastics Corp. 2022-1954 (Fed. Lacerta Group, LLC , No. See Graham v.
Conflict of Laws
JANUARY 15, 2023
The Federal Court Legislation Amendment Rules 2022 (Cth) (‘Amendment Rules’) came into force on 13 January 2023. Among other things, they amend the Federal Court Rules 2011 (Cth) (‘FCR’) by repealing division 10.4, The previous approach to service outside Australia in the Federal Court.
Conflict of Laws
JUNE 11, 2023
In Yin v Wu [2023] VSCA 130 , the Court of Appeal of the Supreme Court of Victoria set aside a judgment [1] which had affirmed the enforcement a Chinese judgment by an Associate Justice of the Supreme Court. [2] On 13 October 2017, Wu commenced a proceeding against Yin in the Ningbo People’s Court.
Patently O
APRIL 1, 2024
by Dennis Crouch In April 2024, the Federal Circuit issued a significant decision vacating a district court’s judgment that Janssen Pharmaceuticals’ dosing regimen patent claims were nonobvious. 2022-1258 (Fed. The case involved Janson’s U.S. Overall, this is a bad case for pharmaceutical formulary patents.
Expert insights. Personalized for you.
59 
Let's personalize your content